MIRA INFORM REPORT

 

 

 

Report Date :           

24.12.2011

 

 

Company name and address

 

 Neuraxpharm Arzneimittel GmbH

 Company Status:      active

 

Main address:

Elisabeth-Selbert-Str. 23

D 40764 Langenfeld

Telephone:02173/10600

Telefax:  02173/1060333

Homepage: www.neuraxpharm.de

 

 

VAT no.            

 

DE265846970

 

 

CONCLUSION

 

 Business relations are permissible.

Registartion data

 

 LEGAL FORM              Private limited company

 Date of foundation:        01.07.2009

 Shareholders'

 agreement:                   01.07.2009

 Registered on:              15.07.2009

 Commercial Register:    Local court 40213 Düsseldorf

 under:                          HRB 61402

 

 

Share capital

 

EUR            800,000.00

 

 

Shareholder

 

HRLG Verwaltungs GmbH & Co. KG

Elisabeth-Selbert-Str. 23

D 40764 Langenfeld

Legal form: Ltd partnership with priv. ltd.

company as general partner

Total cap.         EUR              2,556.46

contribution:

Share:             EUR            800,000.00

Registered on: 01.10.1985

Reg. data: 40213 Düsseldorf, HRA 16075

 

Manager:

Olaf Krause

D 40210 Düsseldorf

having sole power of representation

born: 20.08.1969

 

Proxy:

Lutz Wengert

D 40789 Monheim

having sole power of representation

born: 06.04.1960

Profession: Businessman

 

 

BUSINESS ACTIVITIES

 

 Sectors

 2120   Manufacture of pharmaceutical preparations

46461   Wholesale of pharmaceutical goods

 

 

FINANCIAL INFORMATION

 

 Payment experience:  within agreed terms

 

 Negative information:We have no negative information at hand.

 

 Maximum credit:      100,000 EUR

 

 Balance sheet year:  2009

 

 

REAL ESTATE

 

 Type of ownership:   Tenant

 Address              Elisabeth-Selbert-Str. 23

                      D 40764 Langenfeld

 

 Land register documents were not available.

 

 

BANKERS

 

 COMMERZBANK, DÜSSELDORF

 Sort. code: 30040000, BIC: COBADEDDXXX

 COMMERZBANK VORMALS DRESDNER BANK, DÜSSELDORF

 Sort. code: 30080000, BIC: DRESDEFF300

 COMMERZBANK VORMALS DRESDNER BANK, SOLINGEN

 Sort. code: 34280032, BIC: DRESDEFF342

 SPARKASSE HILDEN-RATINGEN-VELBERT, HILDEN

 Sort. code: 33450000, BIC: WELADED1VEL

 

 

FINANCIAL FIGURES

 

 Turnover:            2009               EUR         68,493,524.00

 Profit:              2009               EUR         24,089,782.00

 Equipment:                              EUR          1,424,507.00

 Ac/ts receivable:                       EUR          9,297,769.00

 Liabillities:                           EUR         12,226,635.00

 Employees:                                                    112

 

 

 BALANCE SHEETS

 

 Balance sheet ratios 01.07.2009 - 31.12.2009

 Equity ratio [%]:                 75.00

 Liquidity ratio:                  10.00

 Return on total capital [%]:      54.60

 Balance sheet grade:                1.0

 

 Equity ratio

 The equity ratio indicates the portion of the equity as compared

 to the total capital. The higher the equity ratio, the better the

 economic stability (solvency) and thus the financial autonomy of

 a company.

 

 Liquidity ratio

 The liquidity ratio shows the proportion between adjusted

 receivables and net liabilities. The higher the ratio, the lower

 the company's financial dependancy from external creditors.

 

 Return on total capital

 The return on total capital shows the efficiency and return on

 the total capital employed in the company. The higher the return

 on total capital, the more economically does the company work

 with the invested capital.

 

 Balance sheet grade

 The balance sheet grade is based on the following ratios: equity

 ratio, liquidity ratio and return on total capital from the

 balance sheets published in the Federal Gazette.

 

 Type of balance

 sheet:               Company balance sheet

 

 Financial year:      01.07.2009 - 31.12.2009

 

 ASSETS                                  EUR         45,686,812.57

  Fixed assets                           EUR         11,953,609.20

   Intangible assets                     EUR          3,125,971.58

    Concessions, licences, rights        EUR          2,904,485.00

    Advance payments for intang. assets  EUR            221,486.58

   Tangible assets                       EUR          8,827,637.62

    Land / similar rights                EUR          7,339,644.39

    Other tangible assets / fixtures and

    fittings                             EUR          1,424,506.90

    Advance payments made / construction

    in progress                          EUR             63,486.33

  Current assets                         EUR         33,686,335.90

   Stocks                                EUR         14,996,872.82

    Raw materials, consumables and

    supplies                             EUR          3,530,000.70

    Finished goods / work in progress    EUR         11,466,872.12

   Accounts receivable                   EUR          9,297,769.32

    Trade debtors                        EUR          7,173,983.68

    Other debtors and assets             EUR          2,123,785.64

   Liquid means                          EUR          9,391,693.76

  Remaining other assets                 EUR             46,867.47

   Accruals (assets)                     EUR             46,867.47

 

 LIABILITIES                             EUR         45,686,812.57

  Shareholders' equity                   EUR         24,889,782.41

   Capital                               EUR            800,000.00

    Subscribed capital (share capital)   EUR            800,000.00

   Balance sheet profit/loss (+/-)       EUR         24,089,782.41

    Annual surplus / annual deficit      EUR         24,089,782.41

  Provisions                             EUR          8,570,394.90

   Other / unspecified provisions        EUR          8,570,394.90

  Liabilities                            EUR         12,226,635.26

   Other liabilities                     EUR         12,226,635.26

    Trade creditors (for IAS incl. bills

    of exchange)                         EUR            545,835.06

    Liabilities due to shareholders      EUR          9,765,775.85

    Unspecified other liabilities        EUR          1,915,024.35

     thereof liabilities from tax /

     financial authorities               EUR            394,995.81

     thereof liabilities from social

     security                            EUR              6,022.89

 

 Profit and loss account (cost-summary method) according to Comm.

 Code (HGB)

  Sales                                  EUR         68,493,524.14

  Inventory change + own costs (+/-)     EUR         -1,047,201.54

   Inventory change (+/-)                EUR         -1,047,201.54

  Other operating income                 EUR          1,028,063.37

  Cost of materials                      EUR         20,765,071.32

   Raw materials and supplies, purchased

   goods                                 EUR          8,671,648.63

   Purchased services                    EUR         12,093,422.69

  Gross result (+/-)                     EUR         47,709,314.65

  Staff expenses                         EUR          6,170,631.82

   Wages and salaries                    EUR          5,161,573.41

   Social security contributions and

   expenses for pension plans and

   benefits                              EUR          1,009,058.41

  Total depreciation                     EUR            818,105.54

   Depreciation on tangible / intangible

   asssets (incl. start-up and exp. of

   bus.                                  EUR            818,105.54

  Other operating expenses               EUR          7,311,518.12

  Operating result from continuing

  operations                             EUR         33,409,059.17

  Interest result (+/-)                  EUR            269,260.12

   Interest and similar income           EUR            413,604.83

   Interest and similar expenses         EUR            144,344.71

    thereof paid to related companies    EUR            122,979.32

  Financial result (+/-)                 EUR            269,260.12

  Result from ordinary operations (+/-)  EUR         33,678,319.29

  Income tax / refund of income tax (+/-)EUR         -9,571,563.88

  Other taxes / refund of taxes          EUR            -16,973.00

  Tax (+/-)                              EUR         -9,588,536.88

  Annual surplus / annual deficit      EUR         24,089,782.41

MIRA INFORM REPORT

 

Report Date :           

14.10.2011

 

IDENTIFICATION DETAILS

 

Name :

NEURAXPHARM ARZNEIMITTEL GMBH

 

 

Registered Office :

Elisabeth-Selbert-Str. 23, D 40764 Langenfeld

 

 

Country :

Germany

 

 

Date of Incorporation :

15.07.2009      

 

 

Com. Reg. No.:

HRB 61402

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture of pharmaceutical preparations

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

100,000 EUR

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Germany

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name & address

 

neuraxpharm Arzneimittel GmbH

 

Main address:

Elisabeth-Selbert-Str. 23

D 40764 Langenfeld

Telephone:        02173/10600

Telefax:             02173/1060333

Homepage:        www.neuraxpharm.de

 

 

VAT no.            

 

DE265846970

 

 

CONCLUSION

 

Business relations are permissible.

 

 

Synthesis

 

 LEGAL FORM              Private limited company

 Date of foundation:        01.07.2009

 Shareholders'

 agreement:                   01.07.2009

 Registered on:              15.07.2009

 Commercial Register:    Local court 40213 Düsseldorf

 under:                          HRB 61402

 Share capital:                EUR            800,000.00

 

 

Shareholder

 

HRLG Verwaltungs GmbH & Co. KG

Elisabeth-Selbert-Str. 23

D 40764 Langenfeld

Legal form: Ltd partnership with priv. ltd.

company as general partner

Total cap.         EUR              2,556.46

contribution:

Share:             EUR            800,000.00

Registered on: 01.10.1985

Reg. data: 40213 Düsseldorf, HRA 16075

 

 

Manager

 

Olaf Krause

D 40210 Düsseldorf

having sole power of representation

born: 20.08.1969

 

 

Proxy

 

Lutz Wengert

D 40789 Monheim

having sole power of representation

born: 06.04.1960

Profession: Businessman

 

 

BUSINESS ACTIVITIES

 

Sectors

 2120   Manufacture of pharmaceutical preparations

 46461   Wholesale of pharmaceutical goods

 

 

FINANCIAL INFORMATION

 

 Payment experience:    within agreed terms

 

 Negative information:     We have no negative information at hand.

 

 Maximum credit:           100,000 EUR

 

 

REAL ESTATE

 

 Type of ownership:        Tenant

 Address                       Elisabeth-Selbert-Str. 23

                                    D 40764 Langenfeld

 

Land register documents were not available.

 

 

BANKERS

 

COMMERZBANK, DÜSSELDORF

Sort. code: 30040000, BIC: COBADEDDXXX

 

COMMERZBANK VORMALS DRESDNER BANK, DÜSSELDORF

Sort. code: 30080000, BIC: DRESDEFF300

 

COMMERZBANK VORMALS DRESDNER BANK, SOLINGEN

Sort. code: 34280032, BIC: DRESDEFF342

 

SPARKASSE HILDEN-RATINGEN-VELBERT, HILDEN

Sort. code: 33450000, BIC: WELADED1VEL

 

 

FINANCIAL FIGURES

 

 Financial year:      01.01. - 31.12.

 Turnover:            2010               EUR         16,000,000.00

 Share capital:                          EUR            800,000.00

 Employees:                                                    112

 

The aforementioned business figures may partly be estimated  information based on average values in the line of business.

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.52.72

UK Pound

1

Rs.82.70

Euro

1

Rs.68.90

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.